About Shweta Kumari

Shweta's profound interest in financial research and quantitative analysis led her to pursue a career as an investment analyst. She uses her knowledge to help retail investors make educated investment decisions.

Shweta graduated with a bachelor's degree in accounting and finance and is currently pursuing the Chartered Accountancy course.


Recent Articles By Shweta Kumari

: MATX |  News, Ratings, and Charts

3 Shipping Stocks That Could Sail Higher in 2025

As global trade sails through shifting tides, fundamentally resilient shipping stocks like Matson (MATX), ZIM Integrated Shipping (ZIM), and Teekay Corp. (TK) are capitalizing on digital transformation. Read on to see why these stocks could sail higher this year.
: NTNX |  News, Ratings, and Charts

3 Next-Gen Cloud Stocks Disrupting the Industry

As cloud computing becomes essential for AI and hybrid systems, next-gen cloud stocks are transforming the industry. Amid this backdrop, companies like Nutanix, Inc. (NTNX), Informatica Inc. (INFA), and Harmonic (HLIT) are poised to benefit from surging cloud investments, making them compelling opportunities for investors. Read on...
: ITRI |  News, Ratings, and Charts

Is Itron Inc. (ITRI) Leading the Charge in Smart Grid Technology?

As smart grids redefine energy management, Itron (ITRI) is leading the charge with billion-dollar deals and next-gen grid solutions. But is this stock primed for sustained growth? Read on to find out…
: RL |  News, Ratings, and Charts

3 High-Growth Retail Stocks to Watch

Retail stocks may have faced short-term turbulence, but the long-term growth story remains intact. With rising disposable incomes, digital transformation, and evolving consumer preferences, companies like Ralph Lauren (RL), Sprouts Farmers Market (SFM), and Carrefour (CRRFY) are positioning themselves for sustained success. Could these high-growth stocks be worth watching? Read on to find out…
: ABBV |  News, Ratings, and Charts

3 Healthcare Stocks Tackling America’s Biggest Medical Challenges

From breakthrough treatments to AI-driven diagnostics, healthcare is evolving faster than ever. With increasing healthcare spending and innovative technologies transforming patient care, companies like AbbVie (ABBV), Gilead Sciences (GILD), and Bristol-Myers Squibb (BMY) are tackling some of the biggest challenges and could be poised for long-term growth. Read more…
: DUK |  News, Ratings, and Charts

3 High-Dividend Utility Stocks for Stable Income

Thanks to rising electricity demand and infrastructure expansion, the utilities sector is making a strong comeback. Amid this backdrop, it could be wise to count on high-dividend utility stocks Duke Energy (DUK), ONEOK (OKE), and Entergy Corp. (ETR) for a stable income stream. Continue reading…
: AAPL |  News, Ratings, and Charts

3 Metaverse Stocks Building the Virtual Economy

The metaverse isn’t just a futuristic fantasy; it’s shaping up to be the next big digital economy. As digital spaces evolve into thriving marketplaces, companies like Apple (AAPL), NVIDIA Corp. (NVDA), and Meta Platforms (META) are building the foundation for this new era. Thus, investing in them could be rewarding. Read more…
: ECL |  News, Ratings, and Charts

3 Waste Management Stocks Profiting from Sustainability Trends

Trash isn’t just trash anymore; it’s a billion-dollar opportunity. With industries going green and consumers demanding sustainability, companies like Ecolab (ECL), Republic Services (RSG), and Clean Harbors (CLH) are turning waste into profit, making them smart picks for a greener portfolio. Learn more…
: MATX |  News, Ratings, and Charts

With Global Trade Rebounding, Is Matson Inc. (MATX) a Shipping Stock to Watch?

As global trade picks up steam and the shipping industry navigates evolving challenges, Matson (MATX) stands out with strong financials and consistent growth. With its latest earnings report on the horizon, could this shipping stock be set for smooth sailing ahead?
: LLY |  News, Ratings, and Charts

3 Pharmaceutical Stocks Betting Big on Weight Loss Drugs

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, pharmaceutical giants like Eli Lilly and Company (LLY), Novo Nordisk (NVO), and Amgen (AMGN) are betting big on next-generation weight loss treatments to dominate this booming market. Keeping reading...
Page generated in 0.9815 seconds.